The phrase "an increased recurrence" is correct and usable in written English.
It can be used when discussing the frequency or rate at which something happens more often than before.
Example: "The study revealed an increased recurrence of the disease in patients who had previously been treated."
Alternatives: "a higher frequency" or "an elevated occurrence".
The timing of treatment is important because applying electric cardioversion too early leads to an increased recurrence of AF [ 106].
In two independant cohorts of colon cancer patients, we observed an association between an increased recurrence risk and the reduced expression of a GPS.
Neural invasion was associated with a significantly lower survival rate and an increased recurrence rate in patients with rectal cancer stage III and IV [ 30].
A review article by Pallure et al. showed that WLE with less than a 3 cm resection margin resulted in an increased recurrence rate [ 29].
Kaplan-Meier curves for TCF12 staining intensity showed an increased recurrence rate for patients with biopsies that have a strong TCF12 staining.
Only truncating mutations showed significant independent prognostic value, with an increased recurrence risk compared to patients with non-modified p53 protein (hazard ratio = 3.21, 95% confidence interval = 1.740 to 5.935, P = 0.0002).
In particular, the evaluation of CDKN1C point mutations and microdeletion/microduplication of chromosome 11p15.5 are required to identify families with a significantly increased recurrence risk.
Information regarding the safety of biologic agents prescribed to patients with prior malignancies is available only from two abstracts from the British Society of Rheumatology Biologics Register (BSRBR) [ 5, 6], one of them indicating a possibly increased recurrence risk for melanoma [ 6].
High-level expression of GATA4 in the primary tumor led to an average threefold increased recurrence risk, independently of tumor stage.
Poor endurance of the multifidus is a predictor of increased recurrence of LBP.
In the highest dietary polyamine group, a non-significant increased recurrence risk was observed after treatment with DFMO+sulindac vs placebo (RR 1.51; 95% CI 0.53 4.29).
